Achilles Therapeutics PLC - Delisted Stock
Achilles Therapeutics PLC is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Achilles Therapeutics was actively traded.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Achilles Therapeutics PLC Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Achilles Therapeutics market risk premium is the additional return an investor will receive from holding Achilles Therapeutics long position in a well-diversified portfolio.
Risk Adjusted Performance | 0.1758 | |||
Jensen Alpha | 0.6915 | |||
Total Risk Alpha | 0.9221 | |||
Sortino Ratio | 0.5067 |
Achilles Therapeutics Corporate Management
Sergio Quezada | Founder Officer | Profile | |
Daniel Hood | General Secretary | Profile | |
Tariq Ahmed | Executive People | Profile | |
James Taylor | Chief Officer | Profile | |
Julia Wilson | Head Communications | Profile | |
Lee Stern | Vice Communications | Profile | |
FMEDSCI MD | Founder | Profile |
Still Interested in Achilles Therapeutics PLC?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achilles Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Achilles Stock
If you are still planning to invest in Achilles Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achilles Therapeutics' history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
CEOs Directory Screen CEOs from public companies around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |